MEDICINE DETAILS
Vyvgart
Active ingredient: Efgartigimod Alfa Fcab
Neutral reference profile for an independent medicine-access consultancy enquiry about Vyvgart (Efgartigimod Alfa Fcab). No medicine is offered for sale.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Vyvgart used for?
Vyvgart (efgartigimod alfa-fcab) is a neonatal Fc receptor blocker used to treat generalized Myasthenia Gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive.
It is available in vial form for intravenous infusion, each containing 20 mg/mL efgartigimod alfa-fcab.
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Vyvgart identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
20 mg/ml (400 mg total) · 1 vial (20 ml) Catalogue organisation: argenx BV
-
1000 mg · 1 vial Catalogue organisation: argenx BV
OFFICIAL SOURCES
Check the Vyvgart record at an official source.
Search for “Vyvgart” or “Efgartigimod Alfa Fcab”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Vyvgart.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Vyvgart
01What is Vyvgart?＋
This directory record associates the brand name Vyvgart with the active ingredient Efgartigimod Alfa Fcab. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Vyvgart strengths and packs are recorded?＋
The catalogue currently shows: 20 mg/ml (400 mg total) · 1 vial (20 ml); 1000 mg · 1 vial. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Vyvgart?＋
Catalogue records currently name: argenx BV. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Vyvgart?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Vyvgart, payment request, stock guarantee or binding offer.
06Can I buy Vyvgart from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.